Jonathan Block
Stock Analyst at Stifel
(4.25)
# 355
Out of 5,182 analysts
227
Total ratings
53.7%
Success rate
14.61%
Average return
Main Sectors:
Stocks Rated by Jonathan Block
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Maintains: Buy | $22 → $20 | $10.65 | +87.79% | 5 | Apr 22, 2026 | |
| NYXH Nyxoah | Maintains: Buy | $10 → $8 | $3.00 | +166.67% | 13 | Apr 10, 2026 | |
| INSP Inspire Medical Systems | Maintains: Buy | $85 → $70 | $55.07 | +27.11% | 16 | Apr 10, 2026 | |
| TRUP Trupanion | Maintains: Hold | $35 → $31 | $27.25 | +13.76% | 18 | Mar 31, 2026 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $775 → $675 | $574.95 | +17.40% | 24 | Mar 31, 2026 | |
| TNDM Tandem Diabetes Care | Maintains: Hold | $20 → $22 | $19.82 | +11.00% | 3 | Feb 20, 2026 | |
| ALGN Align Technology | Maintains: Buy | $200 → $210 | $184.70 | +13.70% | 41 | Feb 5, 2026 | |
| PODD Insulet | Maintains: Buy | $370 → $350 | $188.31 | +85.86% | 2 | Feb 4, 2026 | |
| RMD ResMed | Maintains: Hold | $260 → $265 | $222.02 | +19.36% | 5 | Jan 30, 2026 | |
| COO The Cooper Companies | Reiterates: Buy | $85 → $95 | $64.34 | +47.65% | 20 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $130 | $117.87 | +10.29% | 24 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $9 | $7.27 | +23.80% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $85 | $61.41 | +38.41% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $23 | $22.09 | +4.12% | 15 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $19 → $17 | $11.96 | +42.14% | 13 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $80 → $75 | $77.20 | -2.85% | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $23.42 | -35.95% | 5 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $4 → $2 | $0.88 | +127.04% | 5 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $3.05 | +457.38% | 1 | Nov 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.08 | +270.37% | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $32 → $35 | $122.07 | -71.33% | 5 | Aug 3, 2018 |
Beta Bionics
Apr 22, 2026
Maintains: Buy
Price Target: $22 → $20
Current: $10.65
Upside: +87.79%
Nyxoah
Apr 10, 2026
Maintains: Buy
Price Target: $10 → $8
Current: $3.00
Upside: +166.67%
Inspire Medical Systems
Apr 10, 2026
Maintains: Buy
Price Target: $85 → $70
Current: $55.07
Upside: +27.11%
Trupanion
Mar 31, 2026
Maintains: Hold
Price Target: $35 → $31
Current: $27.25
Upside: +13.76%
IDEXX Laboratories
Mar 31, 2026
Maintains: Buy
Price Target: $775 → $675
Current: $574.95
Upside: +17.40%
Tandem Diabetes Care
Feb 20, 2026
Maintains: Hold
Price Target: $20 → $22
Current: $19.82
Upside: +11.00%
Align Technology
Feb 5, 2026
Maintains: Buy
Price Target: $200 → $210
Current: $184.70
Upside: +13.70%
Insulet
Feb 4, 2026
Maintains: Buy
Price Target: $370 → $350
Current: $188.31
Upside: +85.86%
ResMed
Jan 30, 2026
Maintains: Hold
Price Target: $260 → $265
Current: $222.02
Upside: +19.36%
The Cooper Companies
Dec 5, 2025
Reiterates: Buy
Price Target: $85 → $95
Current: $64.34
Upside: +47.65%
Nov 18, 2025
Maintains: Hold
Price Target: $140 → $130
Current: $117.87
Upside: +10.29%
Oct 21, 2025
Reinstates: Hold
Price Target: $9
Current: $7.27
Upside: +23.80%
Oct 21, 2025
Reinstates: Buy
Price Target: $85
Current: $61.41
Upside: +38.41%
Sep 24, 2025
Maintains: Buy
Price Target: $18 → $23
Current: $22.09
Upside: +4.12%
Aug 8, 2025
Maintains: Hold
Price Target: $19 → $17
Current: $11.96
Upside: +42.14%
Jul 25, 2025
Downgrades: Hold
Price Target: $80 → $75
Current: $77.20
Upside: -2.85%
Feb 27, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $23.42
Upside: -35.95%
Jul 26, 2024
Maintains: Hold
Price Target: $4 → $2
Current: $0.88
Upside: +127.04%
Nov 27, 2023
Reiterates: Buy
Price Target: $17
Current: $3.05
Upside: +457.38%
May 12, 2020
Maintains: Buy
Price Target: $5 → $4
Current: $1.08
Upside: +270.37%
Aug 3, 2018
Maintains: Hold
Price Target: $32 → $35
Current: $122.07
Upside: -71.33%